Gabriele Dorn1, Jonathan Hall, Dieter Hüsken
1Functional Genomics, Novartis Pharma AG, Basel, Switzerland.
Functional genomics generates numerous gene targets for drug discovery. Oligonucleotide-based RNA knock-down technologies help filter and prioritize these candidates for pharmaceutical development.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: